Product Wiki · Recalls · Health Canada — Medical Devices

ADVIA 560 HEMATOLOGY ANALYZER (2016-03-11) — recall 54730

Health Canada — Medical Devices · Canada · 2016-04-04 · Type III

Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked above. No AI-generated text appears on this page. How we use AI →
Agency
Health Canada — Medical Devices
Recall identifier
54730
Date of alert
2016-04-04
Country / jurisdiction
Canada
Risk level
Type III
Risk type
recall
Product category
Medical devices
Product type
Medical devices
Notice status
Archived by the issuing authority — kept for reference
Reported risk: Siemens has identified that software version 1.4.2133 does not trigger the following flags: - the W warning flag for detecting small sample volumes when using the international software configuration. If there is not enough sample volume of the patient's blood when the sample is run, results may be lower than expected. This can occur if the required sample volume as defined in the ADVIA 560 Hematology System operator's guide is not followed. - the G or L morphology flags for immature granulocytes (IG) and atypical lymphocytes (AtLP), respectively. The results from patient samples which have immature granulocytes or atypical lymphocytes will not generate the flags when they should. As defined in the ADVIA 560 Hematology System operator's guide, the immature granulocytes and atypical lymphocyte morphology flags should be raised when the presence of morphologically abnormal cells is suspected indicating that a manual count on a stained smear needs to be performed.
Primary source: https://recalls-rappels.canada.ca/en/alert-recall/advia-560-hematology-analyzer-

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.